What are research peptides?
Peptides are short chains of amino acids linked by peptide bonds. In the scientific literature they are studied as highly specific signalling molecules that interact with cell-surface receptors and enzymes, and the therapeutic-peptide field spans more than a hundred candidates across metabolic, recovery, growth-factor and tissue-repair pathways. In a research context, peptides are typically of interest for recovery, regeneration and signalling studies rather than direct androgen-receptor activity. Our oral Peptides range is supplied as capsules for laboratory research.
How do their mechanisms differ?
The core distinction is the target. SARMs act intracellularly at the androgen receptor, behaving as a single receptor system that influences gene transcription. Peptides are far more diverse: each sequence is studied for its own receptor or enzyme interaction, so a peptide's research profile depends entirely on its amino-acid sequence. This means SARMs are studied as one comparatively uniform mechanism, whereas "peptides" is an umbrella term covering many distinct signalling pathways with no single shared mode of action.
What does the research show?
For SARMs, reviews describe early-stage investigation into muscle wasting, body composition and related endpoints, while also noting that head-to-head clinical superiority over conventional androgens has not been established and that findings remain preliminary. For peptides, the literature documents a large and growing class with several approved peptide medicines in other contexts, alongside many candidates still under study. In both cases the published evidence is the basis for laboratory research interest, not a claim of proven outcomes for any specific compound sold here.
How are they administered in research settings?
Administration format is a practical point of difference often discussed in the literature. Many SARMs are studied as orally bioavailable small molecules. Peptides are frequently fragile in the digestive tract, so historically they have been studied via injectable routes, though oral and other delivery formats are an active area of formulation research. The products referenced here are supplied as research materials and are not formulated, dosed or labelled for human use; no administration guidance for people is provided or implied.
SARMs vs peptides: side-by-side comparison
| Attribute |
SARMs |
Research peptides |
| Chemical class |
Non-steroidal small molecules |
Short amino-acid chains |
| Primary target |
Androgen receptor |
Sequence-specific receptors and enzymes |
| Mechanistic uniformity |
Relatively uniform single-receptor mechanism |
Diverse; varies per peptide |
| Common research focus |
Lean mass, strength, recomposition |
Recovery, signalling, tissue-repair pathways |
| Typical study format |
Often orally bioavailable |
Often injectable; oral formats under research |
| Regulatory status |
Not an approved medicine |
Class includes approved drugs, but research compounds here are not approved medicines |
Which class is studied for which endpoint?
For research framed around mass and strength endpoints, SARMs are the usual starting point because of their androgen-receptor focus. For research framed around recovery, regeneration or specific signalling questions, peptides are more relevant, with the exact choice depending on the sequence and pathway under study. Many research designs reference both classes. None of this constitutes a recommendation for personal use.
Are SARMs and peptides approved medicines in the UK?
No. The SARMs and research peptides referenced here are research compounds and are not authorised medicines. They have not been evaluated or approved as medicines by the MHRA, EMA or FDA, and no medical, therapeutic or performance claims are made for them. They are intended strictly for in-vitro and laboratory research and are not for human or animal consumption. Full breakdown with sources: Legal status of research compounds in the UK
Product listings
Explore the SARMs in our Bioreactive Series and the research peptides in our Peptides range.
Research references
- Solomon ZJ, Mirabal JR, Mazur DJ, Kohn TP, Lipshultz LI, Pastuszak AW. Selective Androgen Receptor Modulators: Current Knowledge and Clinical Applications. Sexual Medicine Reviews. 2019;7(1):84-94. DOI: 10.1016/j.sxmr.2018.09.006
- Bond P, Smit DL, Verdegaal T, de Ronde W. Selective androgen receptor modulators: a critical appraisal. Frontiers in Endocrinology. 2025. DOI: 10.3389/fendo.2025.1634799
- Wang L, Wang N, Zhang W, et al. Therapeutic peptides: current applications and future directions. Signal Transduction and Targeted Therapy. 2022;7:48. DOI: 10.1038/s41392-022-00904-4
Disclaimer: Research compounds sold by Free Muscle are supplied for laboratory research use only and are not for human consumption. They are not authorised as medicines by the MHRA, EMA or FDA, are not food supplements, and are sold only to adults aged 18 or over. Nothing on this page is medical or dosing advice.
